• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Bullish Sentiment Across The Cannabis Space - Check Full Movers For June 5, 2024

    6/5/24 4:30:07 PM ET
    $ACB
    $CARA
    $GENE
    $GRWG
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACB alert in real time by email

    GAINERS:

    • The Flowr (OTC:FLWPF) shares closed up 9900.00% at $0.0001
    • AusCann Group Holdings (OTC:ACNNF) shares closed up 150.00% at $0.01
    • CordovaCann (OTC:LVRLF) shares closed up 40.64% at $0.09
    • Elixinol Wellness (OTC:ELLXF) shares closed up 38.40% at $0.00
    • Rocky Mountain High (OTC:RMHB) shares closed up 23.81% at $0.01
    • CV Sciences (OTC:CVSI) shares closed up 21.25% at $0.10
    • Leafbuyer Techs (OTC:LBUY) shares closed up 13.68% at $0.03
    • Auxly Cannabis Group (OTC:CBWTF) shares closed up 10.54% at $0.02
    • Psychemedics (NASDAQ:PMD) shares closed up 8.62% at $2.37
    • Cannabix Technologies (OTC:BLOZF) shares closed up 8.24% at $0.50
    • Blueberries Medical (OTC:BBRRF) shares closed up 7.99% at $0.01
    • EnWave (OTC:NWVCF) shares closed up 7.12% at $0.17
    • 22nd Century Group (NASDAQ:XXII) shares closed up 6.25% at $0.83
    • 1933 Industries (OTC:TGIFF) shares closed up 4.94% at $0.01
    • Cara Therapeutics (NASDAQ:CARA) shares closed up 4.72% at $0.70
    • Village Farms Intl (NASDAQ:VFF) shares closed up 4.66% at $1.06
    • Target Group (OTC:CBDY) shares closed up 4.12% at $0.00
    • Aurora Cannabis (NASDAQ:ACB) shares closed up 3.90% at $6.09
    • GrowGeneration (NASDAQ:GRWG) shares closed up 3.17% at $2.63

    LOSERS:

    • MPX International (OTC:MPXOF) shares closed down 95.00% at $0.0001
    • Maple Leaf Green World (OTC:MGWFF) shares closed down 45.85% at $0.02
    • Global Hemp Group (OTC:GBHPF) shares closed down 40.00% at $0.03
    • MJ Holdings (OTC:MJNE) shares closed down 33.75% at $0.01
    • Kaya Holdings (OTC:KAYS) shares closed down 14.69% at $0.04
    • Body and Mind (OTC:BMMJ) shares closed down 14.58% at $0.05
    • Indiva (OTC:NDVAF) shares closed down 13.08% at $0.03
    • Nextleaf Solutions (OTC:OILFF) shares closed down 7.68% at $0.08
    • Genetic Technologies (NASDAQ:GENE) shares closed down 5.97% at $1.87
    • SOL Glb Inv (OTC:SOLCF) shares closed down 5.76% at $0.04
    • iAnthus Capital Hldgs (OTC:ITHUF) shares closed down 4.74% at $0.02
    • MariMed (OTC:MRMD) shares closed down 3.67% at $0.21

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACB
    $CARA
    $GENE
    $GRWG

    CompanyDatePrice TargetRatingAnalyst
    Aurora Cannabis Inc.
    $ACB
    1/27/2026Buy
    Canaccord Genuity
    Aurora Cannabis Inc.
    $ACB
    12/11/2024Buy
    TD Cowen
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$6.00 → $1.00Buy → Hold
    Stifel
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$10.00 → $1.00Buy → Hold
    Canaccord Genuity
    Cara Therapeutics Inc.
    $CARA
    6/13/2024Buy → Hold
    Needham
    Cara Therapeutics Inc.
    $CARA
    6/13/2024Buy → Neutral
    H.C. Wainwright
    GrowGeneration Corp.
    $GRWG
    3/20/2024Outperform → Perform
    Oppenheimer
    Aurora Cannabis Inc.
    $ACB
    2/9/2024Hold → Buy
    Canaccord Genuity
    More analyst ratings

    $ACB
    $CARA
    $GENE
    $GRWG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Aiello Stephen bought $221,334 worth of shares (133,334 units at $1.66), increasing direct ownership by 25% to 668,311 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    9/23/25 4:00:54 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    Amendment: Chief Executive Officer Degiglio Michael A bought $30,150 worth of shares (25,000 units at $1.21), increasing direct ownership by 0.26% to 9,783,127 units (SEC Form 4)

    4/A - Village Farms International, Inc. (0001584549) (Issuer)

    6/3/25 9:00:14 PM ET
    $VFF

    Chief Financial Officer Degiglio Michael A bought $30,150 worth of shares (25,000 units at $1.21), increasing direct ownership by 0.26% to 9,783,127 units (SEC Form 4)

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    6/2/25 6:17:22 AM ET
    $VFF

    $ACB
    $CARA
    $GENE
    $GRWG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    22nd Century Group Reports Continued Early Sales Momentum for VLN® Cigarette Products

    Expansion in 2026 Forecasted to Exceed 5,000 Retail Outlets Nationwide as Consumers Demonstrate Interest in VLN® Brands VLN® Remains the Only FDA-Authorized Combustible Cigarette Designed to Reduce Nicotine Consumption MOCKSVILLE, N.C., Feb. 23, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced continued early sales momentum for its VLN® low nicotine cigarette products in the U.S. market. The Company's proprietary low nicotine technology is designed to serve adult smokers who want to change their smoking habits by significantly reducing nicotine consumption. 22n

    2/23/26 5:07:00 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Village Farms Amends and Extends Canadian Cannabis Credit Facility

    Company upsizes loan commitments by CAD $15 million and extends maturities one year to February 2029 Incremental debt capital provides flexibility for additional growth investments at rates below 6.0% VANCOUVER, British Columbia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ:VFF), today announced that on February 20, 2026 it amended and extended its Canadian cannabis credit facility by upsizing loan commitments with existing lenders by CAD $15 million and extending maturities one year to February 2029. The incremental debt financing comes in the form of a delayed draw term loan, from which the Company drew an initial CAD $5

    2/23/26 4:30:00 PM ET
    $VFF

    22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results

    Balance sheet strength, ended 2025 with $7.1 million in cash and debt free, supports transition to growth Continued VLN® commercial expansion drives shift toward higher margin proprietary branded products MOCKSVILLE, N.C., Feb. 20, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced select, preliminary and unaudited financial results and operating metrics for the fourth quarter and full year ended December 31, 2025. The company anticipates releasing fourth quarter and full year 2025 earnings on or before March

    2/20/26 4:15:00 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $CARA
    $GENE
    $GRWG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $CARA
    $GENE
    $GRWG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Aurora Cannabis

    Canaccord Genuity initiated coverage of Aurora Cannabis with a rating of Buy

    1/27/26 9:29:20 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    TD Cowen initiated coverage on Aurora Cannabis

    TD Cowen initiated coverage of Aurora Cannabis with a rating of Buy

    12/11/24 10:35:16 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Cara Therapeutics downgraded by Stifel with a new price target

    Stifel downgraded Cara Therapeutics from Buy to Hold and set a new price target of $1.00 from $6.00 previously

    6/13/24 7:05:24 AM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $CARA
    $GENE
    $GRWG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mclernon John R. converted options into 65,790 shares and covered exercise/tax liability with 17,168 shares, increasing direct ownership by 59% to 130,642 units (SEC Form 4)

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    12/29/25 4:03:37 PM ET
    $VFF

    Director Holewinski David converted options into 65,790 shares, increasing direct ownership by 47% to 204,310 units (SEC Form 4)

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    12/29/25 4:03:07 PM ET
    $VFF

    Director Mahoney Kathleen M converted options into 65,790 shares, increasing direct ownership by 129% to 116,810 units (SEC Form 4)

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    12/29/25 4:02:42 PM ET
    $VFF

    $ACB
    $CARA
    $GENE
    $GRWG
    SEC Filings

    View All

    Village Farms International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Village Farms International, Inc. (0001584549) (Filer)

    2/23/26 4:30:27 PM ET
    $VFF

    22nd Century Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - 22nd Century Group, Inc. (0001347858) (Filer)

    2/20/26 4:15:28 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Aurora Cannabis Inc.

    6-K - AURORA CANNABIS INC (0001683541) (Filer)

    2/12/26 4:26:03 PM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $CARA
    $GENE
    $GRWG
    Leadership Updates

    Live Leadership Updates

    View All

    Village Farms International Creates Global Strategy Officer Role and Appoints Brian Stevenson

    Proven tobacco, pharmaceutical, and cannabis executive will lead the Company's enterprise-wide strategic agenda Appointment underscores the Company's commitment to disciplined global expansion and long-term value creation LAKE MARY, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ:VFF), today announced the appointment of Brian Stevenson to the role of Global Chief Strategy Officer. In this newly created role, Mr. Stevenson will lead the Company's enterprise-wide strategic agenda, including long-term growth strategy, global market assessment, and integration initiatives across regions and business units. Mr. Stevenson wil

    12/17/25 4:30:00 PM ET
    $VFF

    Aurora Names Seasoned Global CPG Executive to Lead Australia and New Zealand

    NASDAQ | TSX: ACB EDMONTON, AB, Dec. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces Kerry Miller, a 35-year consumer packaged goods executive, as Managing Director for Australia and New Zealand, effective January 15, 2026. Kerry will be instrumental in driving growth in these key markets, drawing on decades of global experience in fast moving, regulated industries. "I'm excited to join Aurora at an inflection point in the company's global leadership and to work alongside a team dedicated

    12/8/25 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora Announces Distribution Partnership with Leafio Australia

    The collaboration will improve medical cannabis access and better serve patients across Australia NASDAQ | TSX: ACB EDMONTON, AB, Dec. 2, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, today announced the company's wholly owned subsidiary, MedReleaf Australia, has entered into a distribution partnership with Leafio, the wholesale distribution arm of Montu Australia. This strategic partnership will expand patient access to trusted, safe, and effective medical cannabis across Australia, while supporting healthcare professionals with educational resources. Leafio will serve as a wholesaler of Aurora's leading portfoli

    12/2/25 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $CARA
    $GENE
    $GRWG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/12/24 5:15:40 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Psychemedics Corporation

    SC 13G/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/6/24 9:18:20 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/5/24 6:04:48 PM ET
    $PMD
    Medical Specialities
    Health Care

    $ACB
    $CARA
    $GENE
    $GRWG
    Financials

    Live finance-specific insights

    View All

    22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results

    Balance sheet strength, ended 2025 with $7.1 million in cash and debt free, supports transition to growth Continued VLN® commercial expansion drives shift toward higher margin proprietary branded products MOCKSVILLE, N.C., Feb. 20, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced select, preliminary and unaudited financial results and operating metrics for the fourth quarter and full year ended December 31, 2025. The company anticipates releasing fourth quarter and full year 2025 earnings on or before March

    2/20/26 4:15:00 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora Cannabis Announces Fiscal 2026 Third Quarter Results

    NASDAQ | TSX: ACB Expands YoY Total Net Revenue1 by 7% to $94.2 million, with Global Medical Cannabis Net Revenue1 Increasing by 12% to a Record $76.2 millionDelivers Adjusted EBITDA1 of $18.5 million and Adjusted Net Income1 of $7.2 millionGenerates Free Cash Flow1 of $15.5 million Maintains Strong Balance Sheet with $154.4 million of Cash2 and Short-Term Investments, and a Debt-Free Cannabis Business2EDMONTON, AB, Feb. 4, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter 2026 period ending December 31, 2025.

    2/4/26 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora Cannabis to Host Third Quarter 2026 Investor Conference Call

    NASDAQ | TSX: ACB EDMONTON, AB, Jan. 21, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2026 on Wednesday, February 4, 2026 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the third quarter 2026 before the opening of markets that same day. Conference Call Details DATE: Wednesday, February 4, 2026 TIME: 8:00 a.m. Eastern Time |

    1/21/26 4:35:00 PM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care